Quince Therapeutics, Inc. Share Price
NASDAQ: QNCX | Small CapQuince Therapeutics, Inc. Stock Performance
Quince Therapeutics, Inc. Share Price Today
As of 9 October 2026, Quince Therapeutics, Inc.'s share price is $29.48. The stock opened at $27.32, compared to its previous close of $27.65. During today's trading session, Quince Therapeutics, Inc.'s share price traded between $27.32 and $29.29, with an average price of $28.30. Over the past 52 weeks, the stock has recorded a high of $35.41 and a low of $0.08. In terms of performance, Quince Therapeutics, Inc.'s share price has risen by 2185.27% over the last six months and is up 1665.27% on a year-on-year basis.
Quince Therapeutics, Inc. Share Price Chart
Quince Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Quince Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Quince Therapeutics, Inc.
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
Quince Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $29.95 | $29.29 | -8.45% |
Sep 2026 | $33.11 | $32.00 | -2.63% |
Aug 2026 | $24.80 | $32.86 | +38.83% |
Jul 2026 | $16.77 | $23.67 | +35.37% |
Jun 2026 | $1.13 | $17.48 | +1,413.85% |
May 2026 | $1.30 | $1.16 | -10.47% |
Apr 2026 | $0.10 | $1.29 | +1,216.33% |
Mar 2026 | $0.11 | $0.10 | -19.01% |
Feb 2026 | $0.16 | $0.12 | -28.82% |
Jan 2026 | $3.27 | $0.17 | -94.92% |
Dec 2025 | $3.55 | $3.35 | -8.61% |
Nov 2025 | $1.59 | $3.66 | +119.16% |